Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LACTIN-V for Bacterial Vaginosis
NCT00635622Phase 2Completed
- Sponsor
- Osel Inc.
- Start
- Apr 2008
- Primary completion
- Jan 2009
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of lactobacillus crispatus ctv-05 in bacterial vaginosis (BV), sponsored by Osel Inc.. Started Apr 2008; status: completed.
02
Drugs
lactobacillus crispatus ctv-05
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT00635622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00635622.